Camber Launches Generic Bentyl®

Piscataway, NJ, December 27, 2024 –Camber Pharmaceuticals is excited to announce the addition of Dicyclomine Hydrochloride Capsules, USP.
Dicyclomine Hydrochloride Capsules, USP are an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome.
Dicyclomine Hydrochloride Capsules, USP are available in 10 mg strength, packaged in 100 and 1000 count bottles.
To find out more information on Dicyclomine Hydrochloride Capsules, USP please visit: www.camberpharma.com/dicyclominecapsules
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection